MiNK Therapeutics, Inc. (INKT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 47.61M |
| Enterprise Value | 39.43M |
| P/E Ratio | -4.33 |
| PEG Ratio | 0.37 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -4.63 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.19 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.2 |
| Return On Equity | 0.76 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -181,745 |
| EBITDA | -12.31M |
| Net Income | -12.49M |
| Diluted EPS | -2.93 |
Balance Sheet
| Total Cash | 9.53M |
| Total Cash/Share | 1.99 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.38 |
| Book Value Per Share | -2.64 |
Price History
| 52-Week Change | 63.77 |
| 52-Week High | 76 |
| 52-Week Low | 6.8 |
| Moving Average 50 Days | 11.68 |
| Moving Average 200 Days | 12.18 |
Statistics
| Average Volume | 48,716 |
| Shares Outstanding | 4.98M |
| % Held by Institutions | 2.95 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | January 28, 2025 |
AD
